John G. Bartlett, M.D.
John G. Bartlett, M.D., is a professor of medicine in the Division of Infectious Diseases at The Johns Hopkins University School of Medicine, Baltimore, Md. He served as chief of the Infectious Diseases Division at the school for 26 years, stepping down in June of 2006. Dr. Bartlett received his undergraduate degree at Dartmouth College, Hanover, N.H., and his medical degree at Upstate Medical Center, Syracuse, N.Y. He trained in internal medicine at the Peter Bent Brigham Hospital, Boston, Mass., and the University of Alabama, Birmingham, and he completed his fellowship training in infectious diseases at the University of California, Los Angeles (UCLA).
Before accepting his current position at The Johns Hopkins University, Dr. Bartlett served as a faculty member at UCLA and Tufts University School of Medicine in Boston, Mass., and was associate chief of staff for research at the Boston VA Hospital.
Dr. Bartlett has worked in several areas of research, all related to his specialty in infectious diseases. His major research interests have included anaerobic infections, pathogenic mechanisms of Bacteroides fragilis, anaerobic pulmonary infections, and Clostridium difficile-associated colitis. Since moving to Johns Hopkins, his major interests have been HIV/AIDS, managed care of patients with HIV infection, and bioterrorism.
Dr. Bartlett is a member of the Institute of Medicine, a master of the American College of Physicians, past president of the Infectious Diseases Society of America (IDSA), and a recipient of the Kass Award from the IDSA. In 2005, Dr. Bartlett was awarded the Alexander Fleming Award by the IDSA and the Finland Award from the National Foundation for Infectious Diseases (NFID).
Dr. Bartlett has authored over 500 articles and reviews in peer-reviewed journals, more than 280 book chapters, and 67 editions of 18 books. He has served on editorial boards for 19 medical journals.
Dr. Bartlett has received research support from Gilead Sciences. He serves on the advisory boards of Abbott Laboratories, Bristol-Myers Squibb, GlaxoSmithKline and Pfizer, Inc.